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ABSTRACT Abnormalities in the human microbiota are associated with the etiology
of allergic diseases. Although disease site-speciﬁc microbiota may be associated with
disease pathophysiology, the role of the nasal microbiota is unclear. We sought to
characterize the microbiota of the site of allergic rhinitis, the inferior turbinate, in
subjects with allergic rhinitis (n  20) and healthy controls (n  12) and to examine
the relationship of mucosal microbiota with disease occurrence, sensitized allergen
number, and allergen-speciﬁc and total IgE levels. Microbial dysbiosis correlated sig-
niﬁcantly with total IgE levels representing combined allergic responses but not with
disease occurrence, the number of sensitized allergens, or house dust mite allergen-
speciﬁc IgE levels. Compared to the populations in individuals with low total IgE lev-
els (group IgElow), low microbial biodiversity with a high relative abundance of Firmi-
cutes phylum (Staphylococcus aureus) and a low relative abundance of Actinobacteria
phylum (Propionibacterium acnes) was observed in individuals with high total serum
IgE levels (group IgEhigh). Phylogeny-based microbial functional potential predicted
by the 16S rRNA gene indicated an increase in signal transduction-related genes and
a decrease in energy metabolism-related genes in group IgEhigh as shown in the mi-
crobial features with atopic and/or inﬂammatory diseases. Thus, dysbiosis of the in-
ferior turbinate mucosa microbiota, particularly an increase in S. aureus and a de-
crease in P. acnes, is linked to high total IgE levels in allergic rhinitis, suggesting that
inferior turbinate microbiota may be affected by accumulated allergic responses
against sensitized allergens and that site-speciﬁc microbial alterations play a poten-
tial role in disease pathophysiology.
KEYWORDS inferior turbinate, nasal mucosa, commensal microbiota,
immunoglobulin E, multiple-allergen simultaneous test, skin prick test, allergic
rhinitis, Staphylococcus aureus, Propionibacterium acnes
Allergic rhinitis (AR) is a nasal allergic disease characterized by nasal hyperrespon-siveness, immunoglobulin E (IgE) production, skewing of mucosal immune homeo-
stasis toward a TH2-type response, and accumulation of eosinophils and mast cells (1,
2). AR is a global health problem affecting 25% of the general population, and its
worldwide prevalence has steadily increased over recent decades (3). Intriguingly, the
epidemic is related to increased urbanization, a westernized diet, and overuse of
antibiotics (4). The modern lifestyle reduces exposure to microbes and foreign antigens,
which subsequently increases susceptibility to allergic diseases (5). This high incidence
of allergic diseases is attributed to immature development of, and/or an imbalanced
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antigen response by, the host immune system, a process that relies on cross talk
between host systems and the resident microbiota (6, 7).
The human body is densely populated by complex microbial communities, referred
to as the microbiota. Genetic and environmental factors shape distinct communities of
microbes at different body sites (8, 9). The microbiota plays a crucial role in host
immunity (10). Disturbance or loss of the microbiota, termed dysbiosis, correlates with
asthma and atopic dermatitis (11, 12). Accordingly, abnormalities in the microbiota and
their subsequent effects on the immune system have attracted much attention. Several
studies demonstrate that the commensal microbiota regulates susceptibility to allergic
diseases. The absence of commensal bacteria augments basophil proliferation, in-
creases the total number of inﬁltrating lymphocytes and eosinophils, exacerbates TH2
cell responses and allergic inﬂammation, and reduces the number of RORt regulatory
T cells (Tregs) and TH17 cells (6, 13). Conversely, administration of Lactobacillus strains
to germfree mice induces a TH1-mediated immune response and ameliorates TH2-
related cytokine production and allergic sensitization (14). Furthermore, dysbiosis of the
microbiota increases susceptibility to allergic diseases. Antibiotic-induced dysbiosis of
the gut microbiota promotes food allergies and allergic airway inﬂammation in peanut
allergen- and papain-induced allergy models, respectively (15, 16). Therefore, disrup-
tion of the microbe-host immune system interactions might be a primary cause of
allergic disease. However, the role of alterations in the microbiota in allergic diseases
has been highlighted only for the gut; the role played by the commensal microbiota in
the nasal cavity in the development of AR has not been determined.
The inferior turbinates are the ﬁrst line of immunological defense against external
environmental irritants (17). The inferior turbinates become persistently enlarged in
chronic AR patients, whereas they return to their normal size in healthy individuals. This
mucosal enlargement increases epithelial permeability by stretching intercellular tight
junctions (18) and induces cytokine secretion from ciliated cells or goblet cells, which
eventually alters airway epithelial phenotypes (19). These epithelial phenotypes result
in abnormal liquid accumulation at the airway surface, which, in turn, may affect the
commensal microbiota in the nasal mucosa. In this regard, the local microbiota
interacts closely with the local immune system and may have a direct effect on
pathophysiology at the disease site; however, the association between the commensal
microbiota at the disease site and AR pathogenesis is unknown.
This study aimed to identify the community structure, composition, and functional
potential of the commensal microbiota in the inferior turbinate mucosae of AR patients
and healthy subjects using 16S rRNA gene-based 454 pyrosequencing. The results
suggest that total IgE levels representing combined allergic responses against all
sensitized allergens, rather than AR occurrence or individual allergen-speciﬁc IgE levels,
affect the composition and functional potential of the inferior turbinate mucosa
microbiota.
RESULTS
Comparison of the inferior turbinate mucosa microbiota between AR and
healthy subjects. In this study, inferior turbinate mucosa samples (depicted in Fig. 1A)
and clinical data from a total 32 participants were used. Criteria for participant enroll-
ment and AR diagnosis and group categorizations for each comparison are shown in
Fig. S1. 16S rRNA gene sequencing of inferior turbinate mucosa samples yielded
100,943 high-quality reads (3,145  57 reads per sample). To investigate the effect of
AR on the inferior turbinate microbiota, participants were ﬁrst divided into two groups
according to AR occurrence: one group was diagnosed with AR (n  20; skin prick test
[SPT] positive and multiple-allergen simultaneous test [MAST] positive; group AR),
whereas the other comprised healthy subjects with no AR (n  12; SPT negative and
MAST negative; group AR) (Table 1; see also Table S1 in the supplemental material).
We found no signiﬁcant differences in inferior turbinate microbial community (Fig. S2A
and B), diversity (Fig. S2C), or functional potential (Fig. S2F and G) between the AR
and AR groups, although we did ﬁnd differences in the relative abundances of several
Hyun et al. Infection and Immunity
April 2018 Volume 86 Issue 4 e00934-17 iai.asm.org 2
FIG 1 Effect of immunoglobulin E (IgE) levels on the inferior turbinate mucosa microbiota and microbial diversity and community
composition. (A) Schematic drawing showing harvesting of nasal mucosa from the inferior nasal turbinate. (B) Principal-
coordinate analysis of weighted UniFrac distances of the inferior turbinate mucosa microbiota. Each point represents an
individual microbiota. (C) Average weighted UniFrac distances representing intragroup and intergroup variability within the
microbiota. (D) Comparison of alpha-diversity indices between IgE levels. Bars and dots represent the average diversity index
score and diversity index score, respectively, for each sample. (E) Mean relative abundances of bacterial phyla (inner circles) and
genera (outer circles) in groups IgElow and IgEhigh. Only taxonomic groups at 0.5% of the total microbiota are shown. For panels
C and D, P values were calculated by two-tailed Mann-Whitney U test. *, P  0.05; **, P  0.01; ***, P  0.001.
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taxa (Fig. S2D and E), suggesting that AR occurrence itself was not sufﬁcient for alpha-
or beta-diversity dysbiosis in inferior turbinate mucosa microbiota. Sex or age speciﬁcity
of the inferior turbinate microbiota was not observed (data not shown).
Association of the number of sensitized allergens with the inferior turbinate
mucosa microbiota. AR patients sensitized to multiple allergens (polysensitization) are
known to have more inﬂammation and severe symptoms than those who are sensitized
to a single allergen (monosensitization) (20). AR subjects in our cohorts were sensitized
to one to ﬁve allergens (Table S1). To investigate the inferior turbinate microbiota
according to the number of sensitized allergens, we compared microbiota among three
groups categorized into three sensitization patterns as follows: (i) not sensitized to any
tested allergens (no-sensitization group), (ii) sensitized to only one allergen (monosen-
sitization group), and (iii) sensitized to multiple allergens (polysensitization group).
There were no differences in microbial diversity or community composition among the
three groups (Fig. S3). We further correlated microbiota with the continuous values of
the number of sensitized allergens. The number of sensitized allergens was not
signiﬁcantly associated with microbial community separation (R2  0.11 and P  0.08)
and microbial diversity (R2  0.09 and P  0.06). Taken together, these results
suggested that the number of sensitized allergens was not a direct determinant for
alteration or dysbiosis of inferior turbinate mucosa microbiota.
Comparison of the inferior turbinate mucosal microbiota according to serum
IgE-based allergen sensitivity levels. We hypothesized that the inferior turbinate
microbiota was affected by levels of allergen sensitivity rather than the number of
sensitized allergens. We classiﬁed allergen sensitivity into individual allergen sensitivity
(individual allergen-speciﬁc IgE levels) and combined sensitivity against all sensitized
allergens (total IgE levels). To identify which individual allergen-speciﬁc IgE levels were
associated with the inferior turbinate microbiota in AR patients, we categorized sub-
jects into three groups according to speciﬁc IgE levels against house dust mite allergens
(allergic reaction observed in 90% of AR patients [Table S1]) as follows: (i) low level
(0 to 0.69 IU/ml) (group Mite-IgElow), (ii) intermediate level (0.7 to 17.49 IU/ml) (group
Mite-IgEmed), and (iii) high level (17.5 IU/ml) (group Mite-IgEhigh). Although lower
microbial diversity was observed in the Mite-IgEhigh group, the overall composition of
the microbial community in the inferior turbinate was not signiﬁcantly different among
the three groups, suggesting that individual allergen speciﬁc-IgE levels did not sepa-
rately affect the inferior turbinate microbiota (Fig. S4).
TABLE 1 Subject characteristics
Parameter
Value for subject groupc
Allergic rhinitis
(AR)
Healthy
(AR)
IgE level 3
(IgEhigh)
IgE level 1
(IgElow)
No. of subjectsa 20 12 11 18
Male (%) 16 (80.0) 8 (66.7) 10 (90.9) 11 (61.1)
Female (%) 4 (20.0) 4 (33.3) 1 (9.1) 7 (38.8)
SPT and MAST (%) 20 (100) 10 (90.9) 8 (44.4)
SPT and MAST (%) 12 (100) 1 (9.1) 10 (55.6)
Serum IgE level 3 (%) (range: 200 IU/ml) 10 (50.0) 1 (8.3) 11 (100)
Serum IgE level 2 (%) (range: 100–199 IU/ml) 2 (10.0) 1 (8.3)
Serum IgE level 1 (%) (range: 0–99 IU/ml) 8 (40.0) 10 (83.3) 18 (100)
Age range, yrs 18–57 18–52 19–57 18–52
Mean age, yrs (SEM) 29.2 (2.6) 35.0 (3.1) 32.2 (4.1) 32.8 (2.5)
No. of allergens positive for MASTb,d 2.7 (0.2) 3.3 (0.3) 2.0 (0.4)
Mean levels of MAST reactivityb,e 3.7 (0.2) 4.3 (0.3) 2.9 (0.5)
aAll subjects (n  32) were tested for both AR and total serum IgE levels.
bOnly MAST-positive participants were considered.
cSubjects showing IgE level 3 and IgE level 1 were considered IgEhigh and IgElow, respectively. The three patients with IgE level 2 were omitted for comparative
analysis between the IgE groups.
dA signiﬁcant difference (P  0.016) was observed between the IgE groups (values of 0.05 were considered to indicate signiﬁcant difference).
eA signiﬁcant difference (P  0.011) was observed between the IgE groups.
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Polysensitization is a frequent phenomenon in clinical practice (20). In our study
cohort, most (17 of 20) persistent AR patients were sensitive to multiple allergens. We
assumed that combined allergic responses from multiple sensitized allergens caused by
polysensitization could affect disease phenotype and be used to discriminate the
inferior turbinate microbiota in AR patients. In our study cohort, total serum IgE levels
were positively correlated with a sum of speciﬁc IgE levels of each sensitized allergen
(R2  0.52 and P  0.001) as well as the number of sensitized allergens (R2  0.43 and
P  0.001), indicating that total IgE levels reﬂect combined allergen sensitivity levels.
Participants were divided into groups according to total serum IgE levels as follows: IgE
level 3 (200 IU/ml [IgEhigh]; n  11) and IgE level 1 (0 to 99 IU/ml [IgElow]; n  18)
(Table 1). Principal-coordinate analyses (PCA) revealed signiﬁcant separation between
two clusters according to total IgE levels (analysis of similarity [ANOSIM], P 0.001) (Fig.
1B), indicating that the inferior turbinate microbiota in subjects with high total IgE
levels was different from that in subjects with low total IgE levels. To further clarify the
association between the inferior turbinate microbiota and total IgE levels, but not AR
occurrence, we compared the microbiota among the following three groups: AR/total
serum IgE level 3 (ARIgEhigh), AR/total serum IgE level 1 (ARIgElow), and non-AR/total
serum IgE level 1 (ARIgElow) (Table 2). We found that the microbiota in group
ARIgEhigh was signiﬁcantly different from those in groups ARIgElow and ARIgElow
(ANOSIM, P  0.01) (Fig. S5A and B). However, the microbiota of group ARIgElow was
not signiﬁcantly different from that of group ARIgElow (Fig. S5C). Microbial differences
were clearer when viewed in terms of total IgE levels rather than AR development (Fig.
1C; see also Fig. S5D to F). Taken together, these data suggest that high levels of total
IgE are associated with alterations in the inferior turbinate mucosa microbiota in AR
patients.
Low biodiversity of the inferior turbinate mucosa microbiota in the high total
IgE group. A previous study reported a reduction in skin microbial diversity in
individuals with high IgE levels (21). Both bacterial diversity and richness were signif-
icantly greater in group IgElow than in group IgEhigh (Fig. 1D). Similarly, bacterial
diversity was signiﬁcantly greater in groups ARIgElow and ARIgElow than in group
ARIgEhigh (Fig. S6A). Correlation analysis revealed that total IgE levels were negatively
correlated with bacterial diversity and richness (R2  0.219 and P  0.006 and R2 
TABLE 2 Group categorization according to AR occurrence and total IgE levels
Parameter
Value for group
ARIgElow ARIgElow ARIgEhigh
No. of subjectsa 10 8 10
Male (%) 6 (60.0) 5 (62.5) 9 (90.0)
Female (%) 4 (40.0) 3 (37.5) 1 (10.0)
SPT and MAST (%) 8 (100) 10 (100)
SPT and MAST (%) 10 (100)
Serum IgE level 3 (%) (range: 200 IU/ml) 10 (100)
Serum IgE level 1 (%) (range: 0–99 IU/ml) 10 (100) 8 (100)
Age range, yrs 18–52 18–42 19–57
Mean age, yrs (SEM) 36.0 (3.5) 28.8 (3.1) 31.6 (4.5)
No. of subjects positive for multiple allergens (%) 5 (62.5) 10 (100)
No. of allergens positive by MAST (range)b 1–4 2–5
Mean no. of allergens positive by MASTb,e (SEM) 2.0 (0.4) 3.3 (0.3)
Mean of avg MAST reactivity levelsc,f (SEM) 3.0 (0.5) 4.2 (0.3)
Mean of sum of MAST reactivity levelsd,g (SEM) 5.8 (1.3) 14.1 (1.4)
aTwenty-eight of the 32 subjects were tested for analysis. The three subjects showing IgE level 2 and one subject showing negative SPT and MAST and IgEhigh
(ARIgEhigh) results were excluded.
bNumber of positively reactive allergens in MAST.
cAverage of allergen reactivity levels in each subject based on allergen speciﬁc-IgE levels.
dSum of allergen reactivity levels of all positively reactive allergens.
eA signiﬁcant difference (P  0.016) was observed between the ARIgElow and ARIgEhigh groups (values of 0.05 were considered to indicate signiﬁcant difference).
fFor the difference between the ARIgElow and ARIgEhigh groups, P  0.045.
gA signiﬁcant difference (P  0.001) was observed between the ARIgElow and ARIgEhigh groups.
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0.244 and P  0.004, respectively). These results suggested that a reduction in the
biodiversity of the inferior turbinate mucosa microbiota is associated with high total IgE
levels.
Phylum-level changes in the inferior turbinate mucosa microbial community in
the presence of high total IgE levels. We next examined differences in the compo-
sition of the inferior turbinate microbiota in subjects with high and low levels of total
IgE. Four bacterial phyla, Firmicutes, Actinobacteria, Proteobacteria, and Bacteroidetes,
were dominant in groups IgElow and IgEhigh; however, the relative abundances of these
phyla in groups IgElow and IgEhigh were markedly different (Fig. 1E; see also Fig. S7). The
phylum Firmicutes (60.9%) was signiﬁcantly more abundant in group IgEhigh than in
group IgElow, whereas the phyla Actinobacteria and Bacteroidetes were signiﬁcantly less
abundant (Fig. S7). At the low taxonomic levels, group IgEhigh showed higher levels of
the order Bacillales (Firmicutes) and lower levels of the genera Propionibacterium
(Actinobacteria) and Serratia (Proteobacteria) than group IgElow (Fig. S7). These taxa
were consistently detected in group ARIgEhigh but not in groups ARIgElow and
ARIgElow (Fig. S6 and S8). These results suggest changes in the composition of the
inferior turbinate mucosa microbial community, including alterations in particular
bacterial taxa in the presence of high total IgE levels.
High abundance of Staphylococcus aureus and low relative abundance of
Propionibacterium acnes in the inferior turbinate mucosa microbiota from the
high total IgE group. To characterize key members of the altered inferior turbinate
microbiota in group IgEhigh at the lowest taxonomic level, we selected discriminant
operational taxonomic units (OTUs) using relative abundance-based comparison be-
tween groups IgEhigh and IgElow. Of these, 36 OTUs (0.5%) accounted for an average
74.8% of the OTUs in group IgElow and 89.1% of the OTUs in group IgEhigh. As shown
in Fig. 1D, the low diversity of the microbiota in group IgEhigh may be due to the
dominance of a particular OTU, which was identiﬁed as a member of the Staphylococcus
genus (Fig. 2A). OTU 1078527, assigned to type strain Staphylococcus aureus subsp.
aureus with 100% identity in terms of the 16S rRNA gene, was dominant only in group
IgEhigh despite being present in both groups (Fig. 2B and C). Consistent with the 16S
rRNA sequencing data, the results of quantitative real-time PCR (qPCR) using primers
speciﬁc for the femB gene of S. aureus (22) show that the absolute abundance of S.
aureus was higher in group IgEhigh than in group IgElow (Fig. 2B). Because S. aureus plays
a role in inducing AR and promoting allergic inﬂammation cascades via its toxins and
serine protease-like proteins (23–25), enrichment of S. aureus in group IgEhigh may
aggravate AR. In contrast, the amounts of the Staphylococcus epidermidis-assigned OTU
(99.7% identity) were no different between groups IgEhigh and IgElow (Fig. 2D). S.
epidermidis plays a beneﬁcial role in immune defense devoid of inﬂammation (26). The
Propionibacterium acnes-assigned OTU (100% identity) was detected in all samples but
was more abundant in group IgElow than in group IgEhigh (Fig. 2C and D). In particular,
low levels of the P. acnes-assigned OTU in group IgEhigh were associated with a high
susceptibility to AR; this may be because P. acnes improves atopic symptoms by
inducing TH1 immune responses and Tregs (27). The relative abundance of the OTUs
assigned to Serratia grimesii (100% identity) was lower in group IgEhigh than in group
IgElow (Fig. 2D). Correlation analysis revealed that S. aureus was positively correlated
with total IgE levels (Fig. 3), whereas P. acnes and Serratia grimesii were negatively
correlated with total IgE levels and positively correlated with microbial diversity (Fig. 3),
indicating that microbial dysbiosis was caused by changes in the populations of
particular bacterial taxa. Although the Corynebacterium accolens-assigned OTU (99.7%
identity) showed a higher relative abundance in group IgEhigh than IgElow, the relative
abundance of this OTU was not correlated with total IgE levels or microbial diversity
(Fig. 2D and 3). Taken together, these data suggest that an increase in S. aureus and a
decrease in P. acnes are representative features of the altered inferior turbinate mucosa
microbiota under high total IgE conditions and that enrichment of allergy-prone S.
aureus and loss of allergy-protective P. acnes might be associated with AR aggravation.
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The overall community composition of the inferior turbinate mucosa microbiota is
shown in Fig. 1E and Fig. S9.
Altered microbial functional potential in the inferior turbinate mucosa from
the high total IgE group. To determine differences in the functional potential of the
inferior turbinate microbiota from the different groups, we predicted the metagenomes
of the inferior turbinate microbiota using a 16S rRNA gene data set and compared
differences in predicted functional gene abundance with Kyoto Encyclopedia of Genes
and Genomes (KEGG) orthologs using PICRUSt (28). We found signiﬁcant differences of
functional potential in the total IgE group (ANOSIM, P  0.003) (Fig. 4A and B). To
identify the predicted microbial functional genes that differed between groups IgEhigh
and IgElow, we then compared the relative abundances of 268 KEGG orthology groups
(KOs). At the ﬁrst level of KO hierarchy, we found that group IgEhigh showed higher
relative abundances of two KOs related to human disease and environmental informa-
FIG 2 OTUs that discriminate between two IgE levels, and the predominant OTUs, in the inferior turbinate mucosa microbiota. (A) Each dot
represents mean relative abundance of OTUs in group IgElow (x axis) and group IgEhigh (y axis). OTUs signiﬁcantly enriched in group IgElow are
shown in blue, while those signiﬁcantly enriched in group IgEhigh are shown in red. Nondiscriminant OTUs are shown in black. P values of 0.05
indicated signiﬁcantly discriminant OTUs in both of the two-tailed Mann-Whitney U test and the best-ﬁtted statistical test (either the negative
binomial model, Poisson model, or zero-inﬂated negative binomial model). Only OTUs at 0.5% of the total abundance are shown. (B)
Comparisons of abundances of S. aureus. Two graphs show the mean relative abundance (left) and mean absolute abundance (right) of S. aureus,
respectively. (C and D) Comparison of prevalences (C) and the mean relative abundances (D) of major bacterial OTUs between groups IgElow and
IgEhigh. For panels B and D, P values were determined using the two-tailed Mann-Whitney U test. *, P  0.05; ***, P  0.001.
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FIG 3 Correlation between the relative abundance of major OTUs and total IgE levels and microbial diversity indices
(Spearman’s correlation analysis). The heat maps shown in yellow to green and white to black depict the mean
relative abundances and prevalences, respectively, of the major OTUs. In the heat map showing relative abun-
dance, the OTUs that discriminate between the two IgE groups are marked by a pound sign. The heat map in blue
to red shows the correlation scores (rho) between the relative abundances of major OTUs and total IgE levels and
between the relative abundance of major OTUs and microbial diversity. In the heat map showing the correlation
scores, signiﬁcant P values are indicated by asterisks. A phylogenetic tree based on 16S rRNA gene sequences for
each OTU shows the taxonomic position of the major OTUs. #, P  0.05; *, P  0.05; **, P  0.01; ***, P  0.001.
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FIG 4 Effect of IgE levels on the gene community of the inferior turbinate mucosa microbiota and the microbial gene
characteristics that discriminate between IgEhigh and IgElow groups. (A) Principal-coordinate analysis of Bray-Curtis dissimilarities
in the inferior turbinate microbial gene community. Each point represents an individual predicted microbial functional gene
community. (B) Average Bray-Curtis dissimilarities representing intragroup and intergroup variability within the microbial gene
community structure. (C) Cladograms generated by LEfSe analysis. Shaded areas represent gene families that are signiﬁcantly
enriched in group IgElow or group IgEhigh at the ﬁrst and second levels of KO hierarchy. (D) Heat map depicting normalized
abundance of microbial gene families that discriminate between subjects with different IgE levels. For panels B and D, P values
were determined by the two-tailed Mann-Whitney U test. *, P  0.05; ***, P  0.001. Panel C was generated from the LEfSe
analysis.
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tion processing, and a lower relative abundance of the KO related to metabolism and
organismal systems, than group IgElow (Fig. 4C). At the second level of KO hierarchy, we
found that group IgEhigh showed higher relative abundances of KO families related to
infectious diseases, signal transduction, and membrane transport, and lower relative
abundances of KO families related to metabolism (i.e., amino acid metabolism, second-
ary metabolite biosynthesis, energy metabolism, and metabolism of cofactors and
vitamins), than group IgElow (Fig. 4C and D). The low relative abundance of KOs (i.e.,
amino acid metabolism) speciﬁc to group IgEhigh was also observed in the gut micro-
biome of subjects with FUT2 Crohn’s disease (29) and in the skin microbiome of
individuals with atopic dermatitis (30). A high relative abundance of KOs (i.e., two-
component system of signal transduction) speciﬁc to group IgEhigh was found in cystic
ﬁbrosis patients (31). In addition, enrichment or depletion of several KOs, including
carbohydrate metabolism, energy metabolism, secondary metabolite biosynthesis (de-
pleted in group IgEhigh), signal transduction, and two-component systems (enriched in
group IgEhigh), in group IgEhigh was consistent with predicted microbial functions in
mice with active colitis (32). Taken together, these results indicate that dysbiosis
accompanying alteration of microbiota composition and predicted microbial gene
content occurs in the inferior turbinate microbiota of patients with high levels of total
IgE and that changes in the commensal microbiota within the inferior turbinate may be
associated with the pathogenesis and aggravation of AR.
DISCUSSION
The commensal microbiota plays both regulatory and stimulatory roles during host
immune development, and its dysbiosis provokes aberrant immune responses (6, 10).
Thus, understanding host-microbe interactions under allergic conditions improves our
knowledge of the pathophysiology of AR. However, no study has examined the
association between AR pathophysiology and the commensal microbiota in the nasal
cavity. In this study, we used 16S rRNA gene-based 454 pyrosequencing to characterize
and compare the inferior turbinate mucosa microbiota in healthy controls and AR
patients and found that microbial dysbiosis of the inferior turbinate in the latter is
associated with high levels of total IgE but not with AR occurrence, the number of
sensitized allergens, or house dust mite allergen-speciﬁc IgE. This is the ﬁrst study to
characterize the commensal microbiota in the inferior turbinate (the anatomical site of
AR), and the results underscore the association between dysbiosis of inferior turbinate
microbiota and AR pathogenesis.
Our study found that the inferior turbinate mucosa microbiota was associated not
with AR occurrence or the number of sensitized allergens but with combined allergic
responses from multiple sensitized allergens (represented as total serum IgE level). In
the 20 participants with AR showing differing total serum IgE levels (50% IgE level 3,
10% IgE level 2, and 40% IgE level 1), all but one of the subjects with total serum IgE
level 3 was assigned to the AR group. Also, microbial dysbiosis speciﬁc for high total
serum IgE condition was evaluated through multiple comparisons among the
ARIgElow, ARIgElow, and ARIgEhigh groups. As a result, it is evident that the
composition of the inferior turbinate microbiota from the subjects was associated with
high total IgE levels in AR. Serum IgE is a diagnostic biomarker and a potential
therapeutic target in AR. IgE is secreted by B cells that are stimulated by inhaled
allergens; allergen-IgE cross-linking then triggers allergic inﬂammatory responses (1,
33). Thus, a high IgE level is considered a risk factor for allergen-related symptoms, and
it has been experimentally observed in several studies of allergic diseases (6, 15, 34, 35).
Recently, Cahenzli et al. found that a gut microbiota with a low level of diversity would
lead to increased IgE levels, which cause systemic anaphylaxis; however, a highly
diverse gut microbiota does not lead to hyper-IgE (36). Similarly, we found that low
bacterial diversity within the inferior turbinate microbiota was associated with high
total IgE levels. Taken together, these results support a connection between the
commensal microbiota and total IgE levels in AR.
We noted marked phylum-level changes in the inferior turbinate microbiota in those
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with high IgE levels. Unlike the microbial pattern of the inferior turbinate microbiota
noted in healthy individuals, both previously (37, 38) and in this study, the Firmicutes
phylum was dominant in the inferior turbinate microbiota of AR patients under high IgE
conditions, a condition attributable to low diversity of the inferior turbinate microbiota.
Phylum-level alterations are a widely used marker of microbial dysbiosis related to
human health and disease (39); therefore, this ﬁnding may be a disease-speciﬁc
microbial characteristic of the inferior turbinate environment related to allergic dis-
eases, including AR, although further studies are needed to support this notion.
Individual members of the commensal microbiota are per se expected to have
different immunomodulatory effects in terms of occurrence and progression of allergic
disease. In this study, we observed a high abundance of S. aureus and a low relative
abundance of P. acnes in the altered inferior turbinate microbiota of AR patients with
high levels of total IgE. S. aureus induces IgE production and promotes allergic
inﬂammation (23, 24). Conversely, high IgE levels elicit a bloom of S. aureus, which
activates mast cell degranulation and contributes to inﬂammation (21, 39). Further-
more, S. aureus is known to proliferate in disrupted skin microbiota in atopic dermatitis
(40). In this context, we suppose that allergy-prone S. aureus and IgE may enter a
positive-feedback loop in AR patients with high IgE levels, thereby making both an
individual contribution to allergic inﬂammation and a synergistic contribution when a
bloom of S. aureus organisms occurs. Thus, controlling the levels of both S. aureus and
IgE may be an effective strategy for preventing IgE-associated diseases, including AR. P.
acnes is predominant within the inferior turbinate bacteria population in healthy
individuals (41) and improves atopic symptoms by inducing TH1 and Treg responses
(27); this implies that a low abundance of P. acnes may be associated with AR
aggravation. Our ﬁndings suggest that dominant members of the inferior turbinate
bacteria might be involved in AR progression in individuals with high levels of total IgE.
Consistent with alterations in the composition of the inferior turbinate mucosa
microbiota, we also found alterations of predicted functional genes in subjects with
high IgE levels. The proﬁles of predicted microbial genes in subjects with high IgE levels
differed from those in subjects with low levels. Notably, alterations of predicted
functions similar to those found in the commensal microbiota of individuals with
Crohn’s disease, atopic dermatitis, and cystic ﬁbrosis were observed in the inferior
turbinate microbiota of subjects with high IgE levels (29–31); this implies that disease-
speciﬁc functional features of the inferior turbinate microbiota may contribute to AR
pathophysiology. Polyphasic approaches are needed to better deﬁne the functional
interactions between the host and commensal microbiota.
In summary, we showed that alterations toward to dysbiosis in the composition and
predicted function of the inferior turbinate microbiota in individuals with AR are
associated with high total IgE levels. Importantly, the dominance of S. aureus, known to
promote allergic inﬂammation, in the altered microbiota suggests that microbial dys-
biosis in inferior turbinate microbiota may play an important role in AR development
and progression. This study will help us to understand how the nasal microbiota in the
inferior turbinate environment interacts with the host immune system. Furthermore,
our ﬁndings are preliminary; thus, further studies of microbial dysbiosis in the upper
airway may yield new therapeutic approaches to the management of AR.
MATERIALS AND METHODS
Study design and sample collection. The study was approved by the institutional review board
(IRB) of the Yonsei University College of Medicine (4-2014-0114), and all participants provided
informed consent. A total of 32 subjects (24 men and 8 women), all of whom who underwent
septoplasty, were enrolled, and all met the following criteria: (i) 18 years of age, (ii) receiving no
immunotherapy, (iii) no chronic rhinosinusitis conﬁrmed by computed tomography scans, (iv) not
pregnant or breast-feeding, (v) not diagnosed with malignant neoplasm, (vi) no history of nasal
surgery, (vii) no history of allergic skin diseases and allergic asthma, and (viii) receiving no
medication for the treatment of allergic diseases, including AR, during the previous 2 months (Fig.
S1). Next, the subjects were tested to conﬁrm an AR diagnosis. AR (n  20) was diagnosed when
patients fulﬁlled the following criteria: (i) presenting with persistent rhinitis symptoms (more than
4 days per week and more than 4 weeks) for over 1 year (according to ARIA) (42), (ii) a positive SPT
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(wheal diameter 3 mm larger than that of negative control after 15 min) to at least one allergen,
and (iii) high titer (2 positivity; 0.70 IU/ml) of IgE antibodies speciﬁc for Dermatophagoides farina,
Dermatophagoides pteronyssinus, house dust mite, animal dander, or mold (like Aspergillus) in the
MAST (43) (Fig. S1). Participants (n  12) (i) presenting with no symptoms of clinical rhinitis, such
as chronic sneezing and watery rhinorrhea, (ii) negative by the SPT, and (iii) with the lowest levels
(1 positivity; 0 to 0.34 IU/ml) of allergen speciﬁc-IgE antibodies in the MAST were considered
healthy. Total and allergen-speciﬁc IgE was measured using Advansure Allostation (LG). All patients
in this study were allergic either to perennial allergens or to both seasonal and perennial allergens
(Table S1). Patients allergic to seasonal allergens alone were excluded. Inferior turbinate biopsy
specimens were taken under general anesthesia at the Department of Otorhinolaryngology, Sever-
ance Hospital, from May 2014 to May 2015. A section of inferior turbinate tissue (Fig. 1A) (about 5
by 5 mm) was harvested as previously described (44) and immediately frozen at 80°C. Group
categorization, MAST reactivity, total serum IgE levels, and general patient characteristics are shown
in Table S1.
DNA extraction, 16S rRNA gene ampliﬁcation, and pyrosequencing. Microbial genomic DNA was
extracted from the inferior turbinate biopsy specimens using the repeated-bead beating method (45).
The V1-V2 region of the 16S rRNA gene was ampliﬁed using barcoded forward primer 27F (5=-XXXXXX
XXXX-GAGTTTGATCMTGGCTCAG-3=, where “X” represents the barcode sequence) with an FLX Titanium
adapter, and reverse primer 338R (5=-TGCTGCCTCCCGTAGGAGT-3=) with an FLX Titanium adapter. PCR
mixtures contained 8 l of diluted DNA template (1:7), 2 l of primer mix (0.2 M), and 2 Ex Taq
polymerase premix (TaKaRa) in a total reaction volume of 50 l. PCR conditions were as follows: initial
denaturation at 94°C for 3 min, 28 cycles of denaturation at 94°C for 30 s, annealing at 55°C for 45 s, and
elongation at 72°C for 60 s, with a ﬁnal elongation step at 72°C for 8 min. Amplicons were prepared as
eight replicates and puriﬁed using a QIAquick PCR puriﬁcation kit (Qiagen). DNA concentration was
measured using a Quant-iT PicoGreen double-stranded DNA (dsDNA) kit (Invitrogen). The amplicons
were pooled in equimolar concentrations. Pyrosequencing was performed on a 454 GS-FLX Titanium
sequencing platform (Roche).
Analysis of the inferior turbinate mucosa microbiota. A total of 275,826 raw reads were obtained.
The reads were quality ﬁltered and analyzed using the QIIME platform (46). Picking of operational
taxonomic units (OTUs) (97% identity) was performed against the Greengenes database (2013-08) (47).
Taxonomy was assigned using the RDP classiﬁer against the Greengenes database (47). Unassigned or
non-bacterial kingdom-assigned sequences and singletons were excluded. Finally, 100,943 high-quality
reads (3,145  57 reads per sample) were obtained. From the high-quality reads, each sample was
rareﬁed to 495 sequences to minimize potential bias due to uneven sequencing depth. Alpha-diversity
was then determined using the Shannon diversity index, Chao1, and observed OTUs. Beta-diversity was
determined using PCA on the basis of weighted UniFrac and Bray-Curtis distances. Proﬁles of microbial
functional potential were analyzed using PICRUSt (28). Functional gene families were predicted based on
KEGG orthology groups (48). The predicted functional gene data set was subsampled to 200,000 KOs.
Details are provided in the supplemental material.
Quantiﬁcation of S. aureus organisms in the inferior turbinate mucosa. The absolute abundance
of S. aureus in the inferior turbinate mucosa was estimated by qPCR using primers speciﬁc for the femB
gene of S. aureus (22). Standard curves were generated by plotting the threshold cycle (49) against PCR
products ampliﬁed from genomic DNA derived from an S. aureus isolate from the human inferior
turbinate. The gene copy number in a known amount of ampliﬁed DNA was calculated as described
previously (50). Details are provided in the supplemental material.
Statistical analysis. The statistical signiﬁcance of the different taxonomic and predicted functional
features between groups was determined using two-tailed Mann-Whitney U test. Furthermore, taxo-
nomic and predicted functional characteristics that were deemed signiﬁcantly different between groups
by the Mann-Whitney U test were analyzed using the best of three models: a negative binomial model
(NB), a Poisson model, or a zero-inﬂated negative binomial model (ZINB). The best statistical model was
selected using NegBinSig-Test (https://github.com/alifar76/NegBinSig-Test) based on Bayesian informa-
tion criteria. Characteristics showing signiﬁcance in both of the two statistical tests (Mann-Whitney U test
and the suggested best statistical model [either the NB, Poisson, or ZINB]) were considered signiﬁcant.
Also, discriminant taxonomic and predicted functional characteristics between groups were determined
using the linear discriminant effect size (LEfSe) analysis (https://huttenhower.sph.harvard.edu/galaxy/)
(51). Correlation analysis was performed using Spearman’s rank correlation coefﬁcient. The statistical
analyses, two-tailed Mann-Whitney U test and Spearman’s rank correlation, were performed using
GraphPad Prism software (version 5.0; GraphPad Software). Differences between microbial communities
and predicted microbial functional gene proﬁles between groups were statistically tested using ANOSIM
methods. P values of 0.05 were considered statistically signiﬁcant. Data are expressed as the means 
standard errors of the means (SEMs).
Accession number(s). The metagenome sequences used for this study have been deposited into
the European Nucleotide Archive (ENA) of EMBL-EBI under EMBL accession number PRJEB14731
(ERP016397).
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/IAI
.00934-17.
SUPPLEMENTAL FILE 1, PDF ﬁle, 0.1 MB.
Hyun et al. Infection and Immunity
April 2018 Volume 86 Issue 4 e00934-17 iai.asm.org 12
SUPPLEMENTAL FILE 2, PDF ﬁle, 0.3 MB.
SUPPLEMENTAL FILE 3, PDF ﬁle, 0.5 MB.
SUPPLEMENTAL FILE 4, PDF ﬁle, 0.5 MB.
SUPPLEMENTAL FILE 5, PDF ﬁle, 0.5 MB.
SUPPLEMENTAL FILE 6, PDF ﬁle, 0.6 MB.
SUPPLEMENTAL FILE 7, PDF ﬁle, 0.5 MB.
SUPPLEMENTAL FILE 8, PDF ﬁle, 1.0 MB.
SUPPLEMENTAL FILE 9, PDF ﬁle, 0.3 MB.
SUPPLEMENTAL FILE 10, PDF ﬁle, 0.2 MB.
ACKNOWLEDGMENTS
This work was supported by the Collaborative Genome Program for Fostering
New Post-Genome industry (2015M3C9A2054299), Global Research Lab program
(2016K1A1A2910779), and Mid-career Researcher Program (2016R1E1A1A02921587)
through the National Research Foundation of Korea (NRF) funded by the Ministry of
Science ICT & Future Planning.
We declare no conﬂict of interest.
REFERENCES
1. Galli SJ, Tsai M, Piliponsky AM. 2008. The development of allergic inﬂam-
mation. Nature 454:445–454. https://doi.org/10.1038/nature07204.
2. Sin B, Togias A. 2011. Pathophysiology of allergic and nonallergic rhinitis.
Proc Am Thorac Soc 8:106–114. https://doi.org/10.1513/pats.201008
-057RN.
3. Cruz AA, Bousquet J, Khaltaev N. 2007. Global surveillance, prevention
and control of chronic respiratory diseases: a comprehensive approach.
World Health Organization, Geneva, Switzerland.
4. Strachan DP. 1989. Hay fever, hygiene, and household size. BMJ 299:
1259–1260. https://doi.org/10.1136/bmj.299.6710.1259.
5. Wills-Karp M, Santeliz J, Karp CL. 2001. The germless theory of allergic
disease: revisiting the hygiene hypothesis. Nat Rev Immunol 1:69–75.
https://doi.org/10.1038/35095579.
6. Hill DA, Siracusa MC, Abt MC, Kim BS, Kobuley D, Kubo M, Kambayashi
T, Larosa DF, Renner ED, Orange JS, Bushman FD, Artis D. 2012. Com-
mensal bacteria-derived signals regulate basophil hematopoiesis and
allergic inﬂammation. Nat Med 18:538–546. https://doi.org/10.1038/nm
.2657.
7. Round JL, Mazmanian SK. 2009. The gut microbiota shapes intestinal
immune responses during health and disease. Nat Rev Immunol
9:313–323. https://doi.org/10.1038/nri2515.
8. Spor A, Koren O, Ley R. 2011. Unravelling the effects of the environment
and host genotype on the gut microbiome. Nat Rev Microbiol
9:279–290. https://doi.org/10.1038/nrmicro2540.
9. Turnbaugh PJ, Quince C, Faith JJ, McHardy AC, Yatsunenko T, Niazi F,
Affourtit J, Egholm M, Henrissat B, Knight R, Gordon JI. 2010. Organismal,
genetic, and transcriptional variation in the deeply sequenced gut mi-
crobiomes of identical twins. Proc Natl Acad Sci U S A 107:7503–7508.
https://doi.org/10.1073/pnas.1002355107.
10. Lee YK, Mazmanian SK. 2010. Has the microbiota played a critical role in
the evolution of the adaptive immune system? Science 330:1768–1773.
https://doi.org/10.1126/science.1195568.
11. von Mutius E. 2016. The microbial environment and its inﬂuence on
asthma prevention in early life. J Allergy Clin Immunol 137:680–689.
https://doi.org/10.1016/j.jaci.2015.12.1301.
12. Nylund L, Nermes M, Isolauri E, Salminen S, de Vos WM, Satokari R. 2015.
Severity of atopic disease inversely correlates with intestinal microbiota
diversity and butyrate-producing bacteria. Allergy 70:241–244. https://
doi.org/10.1111/all.12549.
13. Ohnmacht C, Park JH, Cording S, Wing JB, Atarashi K, Obata Y, Gaboriau-
Routhiau V, Marques R, Dulauroy S, Fedoseeva M, Busslinger M, Cerf-
Bensussan N, Boneca IG, Voehringer D, Hase K, Honda K, Sakaguchi S,
Eberl G. 2015. The microbiota regulates type 2 immunity through ROR-
gammat() T cells. Science 349:989–993.
14. Schwarzer M, Repa A, Daniel C, Schabussova I, Hrncir T, Pot B,
Stepankova R, Hudcovic T, Pollak A, Tlaskalova-Hogenova H, Wieder-
mann U, Kozakova H. 2011. Neonatal colonization of mice with Lacto-
bacillus plantarum producing the aeroallergen Bet v 1 biases towards
Th1 and T-regulatory responses upon systemic sensitization. Allergy
66:368–375. https://doi.org/10.1111/j.1398-9995.2010.02488.x.
15. Stefka AT, Feehley T, Tripathi P, Qiu J, McCoy K, Mazmanian SK, Tjota MY,
Seo GY, Cao S, Theriault BR, Antonopoulos DA, Zhou L, Chang EB, Fu YX,
Nagler CR. 2014. Commensal bacteria protect against food allergen
sensitization. Proc Natl Acad Sci U S A 111:13145–13150. https://doi.org/
10.1073/pnas.1412008111.
16. Kim YG, Udayanga KG, Totsuka N, Weinberg JB, Nunez G, Shibuya A.
2014. Gut dysbiosis promotes M2 macrophage polarization and allergic
airway inﬂammation via fungi-induced PGE(2). Cell Host Microbe 15:
95–102. https://doi.org/10.1016/j.chom.2013.12.010.
17. Chhabra N, Houser SM. 2014. Surgery for allergic rhinitis. Int Forum
Allergy Rhinol 4(Suppl 2):S79–S83. https://doi.org/10.1002/alr.21387.
18. Liu Z, Tan JL, Cohen DM, Yang MT, Sniadecki NJ, Ruiz SA, Nelson CM,
Chen CS. 2010. Mechanical tugging force regulates the size of cell-cell
junctions. Proc Natl Acad Sci U S A 107:9944–9949. https://doi.org/10
.1073/pnas.0914547107.
19. Hupin C, Gohy S, Bouzin C, Lecocq M, Polette M, Pilette C. 2014. Features
of mesenchymal transition in the airway epithelium from chronic rhino-
sinusitis. Allergy 69:1540–1549. https://doi.org/10.1111/all.12503.
20. Gelardi M, Ciprandi G, Incorvaia C, Buttafava S, Leo E, Iannuzzi L, Quar-
anta N, Frati F. 2015. Allergic rhinitis phenotypes based on mono-allergy
or poly-allergy. Inﬂamm Res 64:373–375. https://doi.org/10.1007/s00011
-015-0826-9.
21. Oh J, Freeman AF, Program NCS, Park M, Sokolic R, Candotti F, Holland
SM, Segre JA, Kong HH. 2013. The altered landscape of the human skin
microbiome in patients with primary immunodeﬁciencies. Genome Res
23:2103–2114. https://doi.org/10.1101/gr.159467.113.
22. Klotz M, Opper S, Heeg K, Zimmermann S. 2003. Detection of Staphy-
lococcus aureus enterotoxins A to D by real-time ﬂuorescence PCR assay.
J Clin Microbiol 41:4683–4687. https://doi.org/10.1128/JCM.41.10.4683
-4687.2003.
23. Nakamura Y, Oscherwitz J, Cease KB, Chan SM, Munoz-Planillo R, Hase-
gawa M, Villaruz AE, Cheung GY, McGavin MJ, Travers JB, Otto M, Inohara
N, Nunez G. 2013. Staphylococcus delta-toxin induces allergic skin dis-
ease by activating mast cells. Nature 503:397–401. https://doi.org/10
.1038/nature12655.
24. Okano M, Hattori H, Yoshino T, Sugata Y, Yamamoto M, Fujiwara T,
Satoskar AA, Satoskar AR, Nishizaki K. 2005. Nasal exposure to staphy-
lococcal enterotoxin enhances the development of allergic rhinitis in
mice. Clin Exp Allergy 35:506–514. https://doi.org/10.1111/j.1365-2222
.2005.02195.x.
25. Stentzel S, Teufelberger A, Nordengrun M, Kolata J, Schmidt F, van
Crombruggen K, Michalik S, Kumpfmuller J, Tischer S, Schweder T,
Hecker M, Engelmann S, Volker U, Krysko O, Bachert C, Broker BM. 2017.
Staphylococcal serine protease-like proteins are pacemakers of allergic
Inferior Turbinate Microbiota in Allergic Rhinitis Infection and Immunity
April 2018 Volume 86 Issue 4 e00934-17 iai.asm.org 13
airway reactions to Staphylococcus aureus. J Allergy Clin Immunol 139:
492–500.e8. https://doi.org/10.1016/j.jaci.2016.03.045.
26. Naik S, Bouladoux N, Linehan JL, Han SJ, Harrison OJ, Wilhelm C,
Conlan S, Himmelfarb S, Byrd AL, Deming C, Quinones M, Brenchley
JM, Kong HH, Tussiwand R, Murphy KM, Merad M, Segre JA, Belkaid
Y. 2015. Commensal-dendritic-cell interaction speciﬁes a unique pro-
tective skin immune signature. Nature 520:104–108. https://doi.org/
10.1038/nature14052.
27. Kitagawa H, Yamanaka K, Kakeda M, Inada H, Imai Y, Gabazza EC,
Kurokawa I, Mizutani H. 2011. Propionibacterium acnes vaccination in-
duces regulatory T cells and Th1 immune responses and improves
mouse atopic dermatitis. Exp Dermatol 20:157–158. https://doi.org/10
.1111/j.1600-0625.2010.01180.x.
28. Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA,
Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, Beiko RG, Hut-
tenhower C. 2013. Predictive functional proﬁling of microbial commu-
nities using 16S rRNA marker gene sequences. Nat Biotechnol 31:
814–821. https://doi.org/10.1038/nbt.2676.
29. Tong M, McHardy I, Ruegger P, Goudarzi M, Kashyap PC, Haritunians T,
Li X, Graeber TG, Schwager E, Huttenhower C, Fornace AJ, Jr, Sonnen-
burg JL, McGovern DP, Borneman J, Braun J. 2014. Reprograming of gut
microbiome energy metabolism by the FUT2 Crohn’s disease risk poly-
morphism. ISME J 8:2193–2206. https://doi.org/10.1038/ismej.2014.64.
30. Song H, Yoo Y, Hwang J, Na YC, Kim HS. 2016. Faecalibacterium praus-
nitzii subspecies-level dysbiosis in the human gut microbiome underly-
ing atopic dermatitis. J Allergy Clin Immunol 137:852–860. https://doi
.org/10.1016/j.jaci.2015.08.021.
31. Manor O, Levy R, Pope CE, Hayden HS, Brittnacher MJ, Carr R, Radey MC,
Hager KR, Heltshe SL, Ramsey BW, Miller SI, Hoffman LR, Borenstein E.
2016. Metagenomic evidence for taxonomic dysbiosis and functional
imbalance in the gastrointestinal tracts of children with cystic ﬁbrosis.
Sci Rep 6:22493. https://doi.org/10.1038/srep22493.
32. Rooks MG, Veiga P, Wardwell-Scott LH, Tickle T, Segata N, Michaud M,
Gallini CA, Beal C, van Hylckama-Vlieg JE, Ballal SA, Morgan XC, Glickman
JN, Gevers D, Huttenhower C, Garrett WS. 2014. Gut microbiome com-
position and function in experimental colitis during active disease and
treatment-induced remission. ISME J 8:1403–1417. https://doi.org/10
.1038/ismej.2014.3.
33. Gould HJ, Sutton BJ. 2008. IgE in allergy and asthma today. Nat Rev
Immunol 8:205–217. https://doi.org/10.1038/nri2273.
34. Zellweger F, Eggel A. 2016. IgE-associated allergic disorders: recent
advances in etiology, diagnosis, and treatment. Allergy 71:1652–1661.
https://doi.org/10.1111/all.13059.
35. Olivieri M, Heinrich J, Schlunssen V, Anto JM, Forsberg B, Janson C,
Leynaert B, Norback D, Sigsgaard T, Svanes C, Tischer C, Villani S, Jarvis
D, Verlato G. 2016. The risk of respiratory symptoms on allergen expo-
sure increases with increasing speciﬁc IgE levels. Allergy 71:859–868.
https://doi.org/10.1111/all.12841.
36. Cahenzli J, Koller Y, Wyss M, Geuking MB, McCoy KD. 2013. Intestinal
microbial diversity during early-life colonization shapes long-term IgE
levels. Cell Host Microbe 14:559–570. https://doi.org/10.1016/j.chom
.2013.10.004.
37. Bassis CM, Tang AL, Young VB, Pynnonen MA. 2014. The nasal cavity
microbiota of healthy adults. Microbiome 2:27. https://doi.org/10.1186/
2049-2618-2-27.
38. Yan M, Pamp SJ, Fukuyama J, Hwang PH, Cho DY, Holmes S, Relman DA.
2013. Nasal microenvironments and interspeciﬁc interactions inﬂuence
nasal microbiota complexity and S. aureus carriage. Cell Host Microbe
14:631–640. https://doi.org/10.1016/j.chom.2013.11.005.
39. Kobayashi T, Glatz M, Horiuchi K, Kawasaki H, Akiyama H, Kaplan DH,
Kong HH, Amagai M, Nagao K. 2015. Dysbiosis and Staphylococcus
aureus colonization drives inﬂammation in atopic dermatitis. Immunity
42:756–766. https://doi.org/10.1016/j.immuni.2015.03.014.
40. Geoghegan JA, Irvine AD, Foster TJ. 9 December 2017. Staphylococcus
aureus and atopic dermatitis: a complex and evolving relationship.
Trends Microbiol https://doi.org/10.1016/j.tim.2017.11.008.
41. Human Microbiome Project Consortium. 2012. Structure, function and
diversity of the healthy human microbiome. Nature 486:207–214.
https://doi.org/10.1038/nature11234.
42. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale
TB, van Wijk RG, Ohta K, Zuberbier T, Schunemann HJ, Global Allergy and
Asthma European Network, Grading of Recommendations Assessment,
Development and Evaluation Working Group. 2010. Allergic Rhinitis and
its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin
Immunol 126:466–476. https://doi.org/10.1016/j.jaci.2010.06.047.
43. Kim JK, Yoon YM, Jang WJ, Choi YJ, Hong SC, Cho JH. 2011. Comparison
study between MAST CLA and OPTIGEN. Am J Rhinol Allergy 25:
e156–e159. https://doi.org/10.2500/ajra.2011.25.3646.
44. Cho HJ, Lee HJ, Kim SC, Kim K, Kim YS, Kim CH, Lee JG, Yoon JH, Choi JY.
2012. Protease-activated receptor 2-dependent ﬂuid secretion from air-
way submucosal glands by house dust mite extract. J Allergy Clin
Immunol 129:529–535, 535.e1–535.e5. https://doi.org/10.1016/j.jaci
.2011.11.024.
45. Yu Z, Morrison M. 2004. Improved extraction of PCR-quality community
DNA from digesta and fecal samples. Biotechniques 36:808–812.
46. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD,
Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, Huttley GA, Kelley
ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD,
Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J,
Yatsunenko T, Zaneveld J, Knight R. 2010. QIIME allows analysis of
high-throughput community sequencing data. Nat Methods 7:335–336.
https://doi.org/10.1038/nmeth.f.303.
47. DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, Huber
T, Dalevi D, Hu P, Andersen GL. 2006. Greengenes, a chimera-checked
16S rRNA gene database and workbench compatible with ARB. Appl
Environ Microbiol 72:5069–5072. https://doi.org/10.1128/AEM.03006-05.
48. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. 2012. KEGG for
integration and interpretation of large-scale molecular data sets. Nucleic
Acids Res 40:D109–D114. https://doi.org/10.1093/nar/gkr988.
49. Huse SM, Huber JA, Morrison HG, Sogin ML, Welch DM. 2007. Accuracy
and quality of massively parallel DNA pyrosequencing. Genome Biol
8:R143. https://doi.org/10.1186/gb-2007-8-7-r143.
50. Ritalahti KM, Amos BK, Sung Y, Wu Q, Koenigsberg SS, Lofﬂer FE. 2006.
Quantitative PCR targeting 16S rRNA and reductive dehalogenase genes
simultaneously monitors multiple Dehalococcoides strains. Appl Environ
Microbiol 72:2765–2774. https://doi.org/10.1128/AEM.72.4.2765-2774
.2006.
51. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS,
Huttenhower C. 2011. Metagenomic biomarker discovery and explana-
tion. Genome Biol 12:R60. https://doi.org/10.1186/gb-2011-12-6-r60.
Hyun et al. Infection and Immunity
April 2018 Volume 86 Issue 4 e00934-17 iai.asm.org 14
